Name
CEO
Website
Industry
Year Founded
Employees
Bayer AG is a life-science company that develops medicines and agricultural solutions and brings them to market under a single operating philosophy: rigorous science, reliable supply, and guidance that clinicians and growers can use in routine settings. Research feeds clinical and field programs, manufacturing turns validated methods into repeatable production, and local teams adapt access and stewardship to regional rules. The enterprise treats discovery and delivery as one chain, with safety and labeling woven into each step. Healthcare units focus on therapies used in everyday practice, while crop-related units support resilience on farms and in supply networks. Across regions, the aim is to make complex innovation feel workable: instructions that fit the day, inventories that show up, and data that closes the loop between use and improvement. In the healthcare and materials ecosystem, Bayer acts as a long-horizon partner to systems that cannot pause.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Bayer AG's Technical Indicators Summary
BAYNd is exhibiting a strong bullish trend, supported by a robust ADX reading above 60, indicating significant trend strength. Momentum remains positive, with the MACD and CCI signaling continued buying interest, although the RSI and Stochastic are approaching overbought levels, suggesting some caution. The current price sits comfortably above all key moving averages, including the 200-day SMA and EMA, reinforcing the underlying uptrend. Volume trends, reflected by a rising OBV, further validate buying pressure, while volatility is moderate with ATR steady. Despite the price trading slightly below the VWAP and classic pivot point, the overall technical picture remains favorable. In summary, BAYNd maintains strong upward momentum within a clear bullish framework.
| Indicator | Value |
|---|---|
RSI (14) | 70.34 |
Stochastic %K (14, 3, 3) | 86.09 |
CCI (20) | 147.13 |
WPR (14) | -23.27 |
Momentum (10) | 4.88 |
MFI | 73.07 |
MACD Level (12, 26) | 2.44 |
Bollinger Bands | $33.18 - $44.13 |
ATR (14) | $1.30 (3.02%) |
ADX (14) | 61.83 |
OBV | 147,082,705 |
VWAP | $43.41 |
Classic Pivot Point | $44.26 |
Fibonacci Pivot Point | $44.26 |
Simple Moving Averages | $28.17 - $40.80(5 indicators) |
Exponential Moving Averages | $28.95 - $41.09(5 indicators) |
Get premium market insights delivered directly to your inbox.
The session wrapped with BAYNd still elevated after a strong 5.148% gap versus yesterday, ending around 48.30. End-of-day, the peer group was roughly unchanged (-0.10%), limiting broader influence on BAYNd. BAYNd remains elevated amid limited sector movement, reflecting strong recent gains without clear sector-related news.
Price Change
from €45.94 close
+€2.37
Trading Volume
Above avg 2.8M
3.1M
vs S&P 500 Today
Strong Outperformance
+3.11%
52-Week Position
Near highs
95.9%
Updated: February 17, 2026 at 16:02 UTC
Moderna, Mexico sign mRNA vaccine pact
February 11, 2026